PSTV
Plus Therapeutics·NASDAQ
--
--(--)
--
--(--)
1.47 / 10
Underperform
Technical evaluation yields a 1.47/10 composite score, denoting challenging technical structure. Optimistic indicators comprise no significant factors, while Long Lower Shadow, MACD Golden Cross, and Long Upper Shadow warrant caution. The technical perspective remains cautious.
Analysis Checks(0/3)
Long Lower Shadow
Score2.4/10
Win Rate39.32%
Hist. Signals117
Avg Return3.80%
Score2.4/10
Win Rate39.32%
Hist. Signals117
Avg Return3.80%
MACD Golden Cross
Score1/10
Win Rate33.33%
Hist. Signals9
Avg Return-11.85%
Score1/10
Win Rate33.33%
Hist. Signals9
Avg Return-11.85%
Long Upper Shadow
Score1/10
Win Rate29.17%
Hist. Signals96
Avg Return-0.99%
Score1/10
Win Rate29.17%
Hist. Signals96
Avg Return-0.99%
Long Lower Shadow
Score2.4/10
Win Rate39.32%
Hist. Signals117
Avg Return3.80%
Score2.4/10
Win Rate39.32%
Hist. Signals117
Avg Return3.80%
Long Upper Shadow
Score1/10
Win Rate29.17%
Hist. Signals96
Avg Return-0.99%
Score1/10
Win Rate29.17%
Hist. Signals96
Avg Return-0.99%
MACD Golden Cross
Score1/10
Win Rate33.33%
Hist. Signals9
Avg Return-11.85%
Score1/10
Win Rate33.33%
Hist. Signals9
Avg Return-11.85%
Technical Analysis of PSTV?
- PSTV presents a Underperform setup with a Technical Score of 1.47/10. Key technical indicators highlight an RSI of 33.62 and a MACD of 0.01, with the trend anchored by the 50-Day SMA at 0.48. Traders should monitor key support at 0.22 and resistance at 0.24.
